June 2017—Applied Spectral Imaging introduced its HiPath imaging and analysis system, which provides computer-assisted PD-L1 interpretation for research use.
Read More »ARUP Labs, ASI enter collaboration, 2/17
February 2017—Applied Spectral Imaging has entered into a collaboration with ARUP Laboratories to facilitate the development and commercialization of advanced digital pathology solutions, enhancing workflow efficiencies and simplifying the management and accessibility of clinical data.
Read More »FDA clearance for breast cancer analysis platform, 4/15
April 2015—Applied Spectral Imaging has received FDA clearance for its GenASIs HiPath image capture and analysis platform. The ASI platform for immunohistochemistry samples integrates with existing lab microscopes and workflows, aiming to provide labs with a cost-effective solution for digital pathology.
Read More »BioDot, ASI to deliver genetic analysis solution, 7/13:108
Applied Spectral Imaging and BioDot have entered into an agreement under which both companies will engage in combined sales and marketing of a product that will directly link ASI’s GenASIs imaging and analysis instrument and BioDot’s CellWriter automated dispensing system for FISH and karyotyping.
Read More »ASI, WaveSense to provide imaging and analysis instrument and cell enrichment solution, 7/13:105
Applied Spectral Imaging and WaveSense have entered into an agreement in which both companies will engage in combined sales and marketing of ASI’s GenASIs imaging and analysis instrument and WaveSense’s EpiSep cell recovery and enrichment solution. The combined solution provides an integrated cell capturing solution and computerized instrument to detect, image, and analyze the captured cells.
Read More »Computerized IHC cancer analysis aid, 2/13:109
Applied Spectral Imaging recently launched its GenASIs Go-Path computer-aided membrane and nuclear immunohistochemistry imaging and analysis platform.
Read More »